Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT07076212 · RECRUITING
Trial details
- NCT number
- NCT07076212
- Sponsor
- Medical University of South Carolina
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-02
- Primary completion
- 2028-05-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.